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In this issue of Chemistry & Biology, Naegeli and co-
workers [1] show that the nucleotide excision repair
system of mammalian cells detects bulky DNA ad-
ducts, not by recognition of the adduct per se, but
by recognition of the undamaged partner strand in
bulged form.
Human cells contain paternal and maternal copies of
the three billion-rung genomic DNA ladder. Though
tightly packaged in chromatin, genomic DNA suffers an
astounding number of potentially mutagenic chemical
insults each second. Certain DNA functional groups are
susceptible to spontaneous hydrolysis reactions that
alter the pairing potential of DNA bases [2, 3]. Damage
also comes both from outside the organism (ionizing
radiation, UV energy from sunlight, reactive chemicals)
and from within (reactive oxygen species derived from
mitochondrial oxidative metabolism).
DNA represents an ancient solution to the problem of
preserving encoded information, and the cellular re-
sponse to DNA damage appears equally ancient.
Though thousands of kinds of chemical DNA damage
are known, mammals employ just four major DNA repair
systems [4]: end joining (to repair double-strand breaks),
homologous recombination (to rescue damaged infor-
mation using the second copy present near the replica-
tion fork), base excision repair (to replace damaged
bases), and nucleotide excision repair (to repair bulky,
helix-distorting lesions).
Mechanisms of DNA repair have been illuminated by
studies examining model organisms and inherited hu-
man diseases [5]. Despite this progress, many details
of DNA repair remain unclear. This situation is particu-
larly true for the complex nucleotide excision repair
(NER) process, which involves at least 25 different pro-
teins. Seven of these NER proteins are encoded by
genes that, when lost, give rise to an inherited human
cancer disorder called xeroderma pigmentosum (XP)
[6]. XP patients are characterized by extreme sensitivity
to sunlight-induced cancers, suggesting that UV-induced
cyclobutane pyrimidine dimers in DNA are important
substrates for the NER system. The comparison of cell
extracts from normal human cells and cells derived
from XP patients has allowed both in vitro reconstitu-
tion of the first steps of DNA repair on model sub-
strates, and the assessment of the roles of different
XP gene products in the complex NER process (Figure
1) [4, 7].
A fascinating issue in the DNA repair field surrounds
the precise initiating signal that is interpreted as DNA
damage. Unlike the combinatorial chemistry of the im-
mune system, which provides billions of antibodies to
sense different possible “nonself” molecular surfaces,
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igure 1. Simplified Nucleotide Excision Repair Cycle as It Might
ccur during Global Genome Repair
PC protein (orange) recognizes a distortion in the undamaged
NA strand near a lesion (red star). The TFIIH complex (blue) is
ecruited. XPA protein (green) may detect the actual adduct. XPF
violet) and XPG (brown) endonucleases cleave the damaged
trand flanking the lesion. The damaged DNA segment is displaced
uring subsequent repair synthesis. Illustration adapted from [4].he vast number of different bulky DNA lesions must be
etected and handled by a single generic NER system.
hat common feature of damaged DNA triggers the
ER response?
Part of the answer may come from the process of
ranscription-coupled repair itself. Here NER factors are
imply recruited to stalled RNA polymerases [8, 9].
owever, cells also perform a general kind of genome
urveillance called global genome repair that can direct
ER proteins to bulky chemical lesions in the absence
f transcription. It is the initial molecular recognition of
hese DNA adducts that is the focus of a series of
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863of Zürich. A fascinating new installment appears in this
issue of Chemistry & Biology [1].
Previous work by others had established that NER
proteins are assembled in a step-wise fashion at sites
of bulky lesions [10] and that the early steps of NER
can be observed when synthetic radiolabeled DNA
molecules containing model adducts are incubated
with whole-cell extracts [11–14]. Using such in vitro as-
says, NER is detected by the appearance of small in-
ternally radiolabeled excision products containing the
chemical lesion after electrophoresis and autoradiogra-
phy of the processed substrates.
This experimental approach creates an excellent op-
portunity for the combination of synthetic chemistry
(preparation of site-specific bulky adducts on single-
stranded DNA oligonucleotides), clever assembly of
DNA substrates (w150 bp duplex DNA molecules cre-
ated by enzymatic ligation of annealed duplexes with
cohesive termini), and reconstituted repair (extracts
from normal or XP cells). Naegeli and coworkers have
previously applied this strategy to demonstrate surpris-
ing and intriguing results. They first showed that lesions
such as a C4# pivaloyl deoxyribose adduct (which,
though bulky, does not distort the double-helical struc-
ture of DNA) is not recognized by the NER machinery
unless positioned at a site of designed base unpairing
[15]. In subsequent work, the group showed that the
combination of a nondistorting lesion and a site of de-
signed base unpairing could still trigger DNA repair
when the two were separated by as much as 15 bp
[16]. These results suggested that chemical lesions are
detected during global genome repair only when they
are found in the context of a region of stable single-
stranded DNA. Cooperative recognition of the unpaired
site by the XPA protein and the single-strand-specific
protein RPA was suggested.
In the current work [1], the Naegeli group reports the
surprising and counterintuitive discovery that NER
components initiate repair of nondistorting chemical
lesions only when the undamaged complementary DNA
strand is made to adopt a bulged conformation due to
designed base unpairing (Figure 2). On reflection, this
proposal explains how a single NER system can detect
a vast and diverse population of potential substrates:
the common feature shared by all of the lesions is local
unpairing of the undamaged complementary strand.
Buterin et al. [1] report well-reasoned and compre-
hensive experiments with an impressive array of chemi-
cal adducts and analogs to demonstrate the generality
of this interesting result. The authors again begin with
the clever use of the C4# pivaloyl deoxyribose adduct in
construction ofw150 bp internally radiolabeled duplex
DNA substrates by ligation. They confirm that the lesion
itself does not cue NER, except when base unpairing
is detected in the undamaged complementary strandFigure 2. Schematic Summary of the Results
of Buterin et al.
Excision of a bulky but nondistorting DNA
lesion (red star) requires bulged unpairing in
the undamaged DNA strand.at, or flanking, the lesion. The study goes on to show
that perturbation of the undamaged strand, either by
a second lesion or by the presence of unnatural base
analogs, inhibits repair. Using site-specific benzo[a]py-
rene or acetylaminofluorene adducts, the authors gen-
eralize their result by showing that initiation of repair
crucially depends upon at least one unpaired base on
the undamaged DNA strand in the vicinity of these
lesions. The XPC protein is proposed as a first sensor
of unpaired DNA (even in the absence of a chemical
adduct), although NER will not proceed to excision
without subsequent detection of a bulky lesion. The
present results are also consistent with the observa-
tions of others [17, 18].
Future studies will be required to understand what
features of the unpaired and undamaged strand (ex-
posed hydrogen bonding functions of the bases, hy-
drophobic character, flexibility, nonhelical conforma-
tion?) are recognized by XPC, and how these properties
might be detected in the context of chromatin during
global genome repair. Techniques to assemble chemi-
cally modified templates into plasmids for transient
transfection into living cells may eventually be required.
For the moment, the report of Buterin et al. provides a
particularly fine illustration of chemical keys serving to
unlock a biological mystery.
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